Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nehemie Mbakuliyemo"'
Autor:
Patrick L.F. Zuber, Bartholomew Dicky Akanmori, Samba O. Sow, Téné M. Yaméogo, Modibo Keita, Mamoudou Harouna Djingarey, Simonetta Viviani, Nehemie Mbakuliyemo, Kirsten S. Vannice, Fabien Diomandé, Marie-Pierre Preziosi, Claude-Roger Ouandaogo
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
A group A meningococcal conjugate vaccine, PsA-TT, was developed by the Meningitis Vaccine Project and the Serum Institute of India, Ltd (SIIL). Clinical trials conducted among approximately 10 000 persons aged 1–29 years, in India and in Africa, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39de76e27090cc449d824514e23aedc4
http://europepmc.org/articles/PMC4639501
http://europepmc.org/articles/PMC4639501
Autor:
Charles Sawadogo, Fabien V.K. Diomandé, Claude-Roger Ouandaogo, Patrick L.F. Zuber, Rasmata Ouédraogo-Traoré, Nehemie Mbakuliyemo, Lorenzo Pezzoli, Téné M. Yaméogo, Mamoudou Harouna Djingarey, Bassirou Ouedraogo
Publikováno v:
Vaccine. 30:B46-B51
MenAfriVac™ is a new meningococcal A conjugate vaccine developed to prevent meningitis outbreaks in Africa. It was first introduced during the last quarter of 2010 in three West African countries. We report on the monitoring of adverse events follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96cf68bcaa86a8afeb1bda76392f1f36
https://doi.org/10.1016/j.vaccine.2011.12.112
https://doi.org/10.1016/j.vaccine.2011.12.112
Autor:
Kadidja Gamougam, Nehemie Mbakuliyemo, Denis Kandolo, Nancy E. Messonnier, James M. Stuart, F. Marc LaForce, Jean-Marc Collard, Paul A. Kristiansen, Ryan T. Novak, Doumagoum M. Daugla, William Perea, Brian Greenwood, Fabien Diomandé, Carol Tevi-Benissan, Mamoudou Harouna Djingarey, Marie-Pierre Preziosi, O. Walker, Thomas A. Clark, Dominique A. Caugant, Leonard W. Mayer
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2015, 61 (suppl_5), pp.S467-S472. ⟨10.1093/cid/civ499⟩
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, Oxford University Press (OUP), 2015, 61 (suppl_5), pp.S467-S472. ⟨10.1093/cid/civ499⟩
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
International audience; Background. During the first introduction of a group A meningococcal vaccine (PsA-TT) in 2010–2011 and its rollout from 2011 to 2013, >150 million eligible people, representing 12 hyperendemic meningitis countries, have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0f832aac82940364ba93875da5c003
https://researchonline.lshtm.ac.uk/id/eprint/2551457/1/civ499.PMC4639484.pdf
https://researchonline.lshtm.ac.uk/id/eprint/2551457/1/civ499.PMC4639484.pdf
Autor:
Filmona Bisrat, Teklay Kidane, Babaniyi Olusegun, Hiwot Mengistu, Tesfaye Bulto, Tesfanesh Belay, Asnakew Yigzaw, Yodit Sahilemariam, Daniel Benti, Nehemie Mbakuliyemo
Publikováno v:
Ethiopian Journal of Health Development; Vol 22, No 2 (2008); 148-157
Background: Routine EPI reports have shown an upward trend in immunization coverage in recent years in Ethiopia, however, regional disparities exist. Objective: To determine regional coverage of child and TT immunization and assess reasons for not ut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cfa3f6e9dcbf0a92a2467101b76335d
https://www.ajol.info/index.php/ejhd/article/view/10065
https://www.ajol.info/index.php/ejhd/article/view/10065